Panacos News (NASDAQ:PANC)
| Latest Panacos Pharmaceuticals News Headlines | | Date | Time | Source | | | 11/11/2005 | 6:32PM | PRNUS | Semi-Annual Changes to the NASDAQ Biotechnology Index
NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- The Nasdaq Stock Market, Inc. ("NASDAQ") (NASDAQ:NDAQ) announced today the results of the semi-annual re- ranking of the NASDAQ Biotechnology Index(R) (NASDAQ:NBI), which will become effective with the market open on Monday, November 21, 2005.
The re-ranking will result in... More...>> |
| 10/06/2005 | 7:16AM | PRNUS | Panacos Announces Pricing of Common Stock Offering
WATERTOWN, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the pricing of its public offering of 8,250,000 shares of its common stock... More...>> |
| 09/28/2005 | 7:46AM | PRNUS | Panacos Announces Proposed Offering of Common Stock
WATERTOWN, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that it has filed a preliminary prospectus supplement to its two shelf... More...>> |
| 09/07/2005 | 8:57AM | PRNUS | Panacos and Leading HIV Clinicians to Discuss PA-457 Clinical Trial Results
Analyst Briefing to be Held in New York on September 22, 2005
WATERTOWN, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company") today announced that it will hold a meeting for invited analysts and investment professionals on Thursday, September 22, 2005 from... More...>> |
| 09/06/2005 | 6:02PM | PRNUS | Panacos Files Shelf Registration Statement
WATERTOWN, Mass., Sept. 6 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that it has filed a shelf registration statement on Form S-3 with the Securities... More...>> |
| 09/06/2005 | 1:17PM | PRNUS | Panacos to Present at the Bear Stearns 18th Annual Healthcare Conference
WATERTOWN, Mass., Sept. 6 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, has been invited to speak at the Bear Stearns Annual Healthcare Conference, to be held at... More...>> |
| 08/22/2005 | 6:00AM | PRNUS | Panacos Drug Candidate PA-457 Shows Potent Antiviral Activity in HIV-infected Patients
Viral Load Reduction Meets Primary Endpoint of Phase 2a Study
WATERTOWN, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the successful... More...>> |
| 08/18/2005 | 8:01AM | PRNUS | Panacos Appoints Peyton Marshall Executive Vice President and CFO
WATERTOWN, Mass., Aug. 18 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the appointment of Peyton J. Marshall, Ph.D. to the position of Executive... More...>> |
|
|
|